Loading…
Perceptive Life Sciences Fund makes global investments in public and private biotechnology products, including drugs, medical devices and diagnostics, with over 25 years of experience. It invests across a company's life cycle, including growth-stage investments, crossover rounds, leading IPOs and public follow-on financings, and the majority of its investments are in small- to mid-cap publicly traded companies. The investment team uses a fundamental scientific approach to identify opportunities and deploy capital across healthcare to support robust development programs.
AI named Perceptive Life Sciences Fund in January 2026.